Patogénese da aterosclerose, 2ª. Parte
Palavras-chave:
aterosclerose, patogénese, teoriasResumo
Os autores continuam a discutir algumas das teorias da aterogénese, abordando, nesta segunda parte, a evidência científica que fundamenta a teoria imunológica, o papel do cálcio neste processo, a importância da patologia infecciosa, a teoria da fadiga, defendida por Stehbens, e a determinância da teoria hemodinâmica. Por fim, conclui-se pela interdependência de todas as teorias e hipóteses que, em conjunto e com maior ou menor peso relativo, desenbocam na doença aterosclerótica, cuja manifestação clínica precoce todos receamos.
Downloads
Referências
Ip JH, Fuster V. Badimon L. Badirnon J, Taubrnan M B. Che,ebro J H. Syndrome, of accelerated atherosclerosis role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990: 15: 1667-1687.
Libby P. Han.sson G K. Biology of disease. lnvolvement of lhe immune system in human atherogenesis: current knowledge and unanswerd questions. Lab lnvest 1991: 64: 5-15.
Libby P. Salomen R N. Payne D D. Schoen F J. Pober J S. Function, of vascular wall cells related to the development of transplantation associated coronary arterioesclorosis . Transplantation Proc 1989: 21: 3677-3684.
Alonso D. Starek P. Minick C. Studies on lhe pathogenesis, of atheroarteriosclerosis, induced in rabbit cardiac allografts by the
Synergy of graft rejection and hypercholestcrotemia. Am J Pathol 1977: 87: 415-442.
Bulkley B H. Robert, W C. The heart in systemic lupus, erythematosus and the changes, induced in it by corticosteriod therapy. Am J Med 1975: 58: 243-264.
D'Anastasio C. Impallorneni M. McPherson G A D. Clement, WG. Howell, G L. Brooks P A. Batchelor J R. Antibodies, against monocyte, and endothelial cells in the sera of patient, with atherosclerotic peripheral arterial disease. Atherosclerosis 1988: 74: 99-105
Hailu C. Lianbi Y. Shiming Z. Hongfen L. Lixin W. lmmunemediated acceleraled atherosclerosis, of failed kidney allografs. 62nd EAS Congress, Abstracts 199.1. pág 131.
Minick C R. Murphy G E. Experimental induction of arteriosclerosis by the sinergy of allergic injury lo arteries anti lipid rich diet. II. Effect of repeatedly injected foreign protein in rabbits fed a lipid rich. cholesterol-poor diet. Am J Pathol 197.1: TI: 26.'i-.100.
Cerilli J. Bra,ile L. Karmody A. Role of the vascular endothclial cell antigen system in the etiology of atherosclerosis. Ann Surg 1985: 202 .329-334.
Fyfe A I. Qiao J-H. Lusis A J. The immune system is not essential for the development 0f aortic atherosclerotic plaques in mice fed an atherogenic diet. Xth Inernational Symposium on Atherosclerosis Abstracts. Athcrosclerosis 1994: 109 ( 1.2): 8.
Stemme S. Hansson G K. lmmune mechanisms in atherosclerosis. Coronary Artery Di 1994: .5: 216-222.
Drew A F. Tipping P G. Cyclosporine treatment reduces early atherosclerosts in lhe cholesterol-fed rabbit. Atherosclerosis 1995: 116: 181-1893
Matsumura T. Kugiyama K. Sugiyarna S. Ota Y. Doi H. Ogata N. Oka H. Yasue H. Suppression of atherosclerotic development in watanahe heritable hyperlipidemic rabbits treated with na oral antiallergic drug. tranilast. Circulation 1999: 99: 919-924.
Boyd H C. Gown A M Wolfbauer G. Chait A. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol 1989: 135: 815-825
Ylä-Herttuala S. Palinski W. Butler S W. Picard S. Steinberg D. Witztum J L. Rabbit and human atherosclerotic lesions contain lgG that recognizes epitopes of oxidized LDL. Arterioscl Thromb 1994: 14: 32-40.
Steinberg D. Parthasarathy S. Carew T E. Khoo J C. Witzum J L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989: 320: 915-924.
Orekhov A N. Kalenich O S. Tertov V V. Perova N V. Novikov I D. Lyakishev A A. Deev A D. Ruda M Y. Diagnostic value of immune cholesterol as a marker for atherosclerosis. J Cardiovasc Risk 1995: 2: 459-466.
Witzum J. Steinhrecher U. Kesaniemi Y. Fisher M. Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus. Proc Natl Acad Sci USA 1984: 81: 3204-3208.
Salonen J T. Yiä-Herttuala S. Yamamoto R. Butler S. Korpela H. Salonen R. Nyyssonen K. Palinski W. Witztum J L. Antibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992: 339: 883-887.
Puurunen M. Manttari M. Manninen V. Tenkanen L. Alfthan G. Ehnholm C. Vaarala O. Aho K. Palosuo T. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch lntern Med 1994: 154: 2605-2609.
Beaumont J L. Doucet F. Vivier P. Antonucci M. Immunoglobulinbound lipoproteins 1 lg-Lp) as markers of familiar hyper cholesterotemia. xanthomatosis and atherosclerosis. Atherocleros 1988: 74: 191-201.
Feingold K. Castro G. lshikawa Y. Fielding P. Fielding C. Cutaneous xanthoma, in association with paraproteinemia in the abscnce of hyperlipidemia. J Clin lnvest 1989: 83: 796-802.
Kiener P A. Rankin B M. Davis, P M. Yocum S A. Warr G A. Grove R 1. lmmune complexes of LDL induce atherogenic responses in human monocytic cell. Arterioscl Thromb Vasc Biol 1995: 15: 990-999.
Deniscnko A D. Makovejchuk E G. Vinogradov A G. Kuznetzov A S. Klimov A N. Autoantihndies against oxidized LDL and lipoprotein-antihody (Lp-Ah) autoimmune complexe., in human atherosclerosis. Xth lnternational Symposium on Atherosclerosis Abstract,. Atherosclerosis 1994: 109 (1.2): .38.
Xu Q. Willeit T. Marosi M. Kleindienst R. Oberhollenzcr F. Kiechl S. Stulnig T. Luef G. Wick G. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 1993: 341: 255-259.
Kaufmann S H. Heat shock protein, and the immune response. lmmunol Today 1990: 11: 129-136.
Kleindienst R. Xu Q. Willeit J. Waldenherger F R. Weimann S. Wick G. Demonstration of heat shock protein 60 expression and T lymphocytes, bearing a/b or g/d receptor in human atherosclerotic lesion,. Am J Pathol 199.1: 142: 1927-1937.
Xu Q. Kleindienst R. Waitz W. Dietrich H. Wick G. lncreased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocyte, in atherosclerotic lesions of rabbits specifically responding to heat shod protein 65. J Clin lnvest 1993: 91: 269.1-2702.
Berberian P A. Myer, W. Tytcll M. Challa V. Bond M G. lmmunohistochemical localization of heat shock protein-70 in normal appearing aned atherosclerotic specimens of human arteries. Am J Pathol 1990: 136: 71-80.
Xu Q. Wick G. The role of heat shock protein 60 in atherogenesis. 62nd EAS Congress Abstracts 1993. pág 19.
Hansson G K. lmmunological markers of atherosclerosis. Lancet 1993: 341: 278-279.
Seifert P S. Hugo F. Tranum-Jensen J. Zahringer U. Muhly M. Bhakdi S. lsulation and characterization of a complernent activating lipid extracted from human atherosclerotic lesions. J Exp Med 1990: 172: 547-557.
Saito E. Fujioka T. Kanno H. Ueno T. Matsurnoto T. Takahashi Y. Watanahe H. Tochihara T. Kamnatsuse K. lnfluence of oxidized LDL on secretion of the third component of complement (C3) by cultured human peripheral monocyte-derived macrophages. Xth lnternational Symposium Atherosclerosis' Abstracts. Atherosclerosis 1994: 109 ( 1.2): 198.
Hansson G K. Holm J. lnterferon-g inhibits arterial stenosis after trauma. Circulation 1991: 84: 1266-1272.
Emeson E E. Shen M L. Accelerated atherosclerosis in hypcrlipidcmic C57BL/6 mice treated with cyclosporin A. Am J Pathol 1993: 142: 1906-1915.
Born G. Pathogenesis of atherosclerosis. 62nd EAS Congress Abstracts 199.1. p. 53.
Qiao J-H. Xie P-Z. Fishbein M C. Kreuzer J. Drake T A. Demer LL. Lusis A J. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscl Thromb 1994: 14: 1480-1497.
Fleckenstein A. Frey M. Fleckenstein-Grün G. Antihypertensive and arterial anticalcinotic effects of calcium antagonists. Am J Med 1986: 57: 1D-10D.
Teng W. Wnng N D. Abrahmm.on D Gardin J. Relation of electron beam computed tomography screening for coronary calcium to cardiovascular risk and disease: a review. Coronary Artery Dis 1996: 7: 383-389.
Wagner W D. St. Clair R W. Clarkson T B. Connor J R. A study of atherosclerosis regression in macaca mulatta. III. Chemical changes in arteries from animais with atherosclerosis induced for 19 months and regressed for 48 months al plasma cholesterol concentrations of 300 or 200 mg/dl. Am J Pathol 1980: 100: 63.1-650.
Seely S. The connection between lactose and coronary artery disease. lnt J Cardiol 1995: 48: 199-200.
Loecker T. Schwartz R. Cotta C. Hickman J. Fluoroscopic coronary artery calcification and associated coronary disease in
asymptomatic young men. JACC 1992: 19: 1167-1172.
Bobryshev Y V. Lord R S. Warren B A. Calcified deposit formation in intimal thickenings of the human aorta. Atherosclerosis 1995: 118: 9-21.
Fleckenstein A. Frey M. Thimm F. Fleckenstein-Grün G. Excessive mural calcium overload. A predominant causal factor in the development of stenosing coronary plaques in humans. Cardiov Drugs Ther 1990: 4 (suppl 5): 1005-1013
Stanford W P. Boström K. Watson K E. Demer L L. Osteoinduction of a pluripotent mesenchymal cell line (C3H 10Tl/2) by endothelial cell-conditioned media. Xth lnternational Symposium on Atherosclerosis Abstracts. Atherosclerosis 1994. 109 (1.2): 194
Shanahan C. Cary N. Metcalfe J. Weissberg P. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin lnvest 1994: 93: 2393-2402.
Watson K. Demer L. The atherosclerosis-cakification link?. Curr Op Lipidol 1996: 7: 101-104.
Dahlen G. Ericson C. Berg K. ln vitro studies of the intercation or calcium ions and other divalent cations with the Lp(aJ lipoprotein and other isolated serum lipoproteins. Clin Genet 1978: 14: 115- 124.
Tanaka S. Yashiro A. Tasaki H, Nakashima Y. Enhanced macrophage uptake of lipoprotein(a) after Ca2+-induced aggregate formation. Lipids 1998: 33: 385-392.
Haria M. Wagstall A J. Amlodipine. A reappraisal of its pharmacological properties and therapcutic use in cardiovascular disease. Drugs 1995: 50: 560-586.
Nayler W G. The antiatherosclerotic effect or the calcium antagonists and their implications in hypertension. Am Heart J 1993: 125: 626-629.
Baron J. Beach M. Mandei J. Stolk R. Haile R. Sandler R. Rothstein R. Summers R, Snover D. Beck G. Bond J. Greenberg E. Calcium supplements for the prevention of colorectal adenomas. N Engl J MecJ 1999: 340: 101-107.
Fisher M. Grotta J. New uses for calcium channel blockers. Therapeutic implications. Drug.s 1991: 46: 961-975.
Haller H. Calcium antagonists and cellular mechanims of glomerulosclerosis and atherosclerosis. Arn J Kidney Dis 1991:
(suppl 11: 26-31.
Henry P D. Calcium antagonists as antiatherogenic agents. Ann N Y Acad Sci 1988: 522: 41 1-419.
Holzgreve H. Bürkle B. Anti-atherosclerotic effects of calcium antagonists. J Hypertension 1993: 11 (suppl 11: S55-S59.
Lichtlen P R. Hugenholtz P G. Rafllanbeul W. Hecker H. Josi S. Deckers J W. on behalf of the INTACT group investigators. Retardation of angiographic progression on coronary artery disease by nifedipine. Results of the international Nifedipine trial on antiatherosclerotic therapy ( INTACT). Lancet 1990: 335: 1109-1113
Ferguson J J. Meeting highlights. Circulation 1999: 99: 2486-2491.
Borcherding S M. Meeves S G. Klutman N E. Howard P A. Calcium channel antagonists for prevention of atherosclerosis. Ann Pharmacotherapy 1993: 27: 61-67.
Ko Y. Totzke G. Graack G H. Heidgen F J. Brickwedde M K. Düsing R. Vetter H. Sachinidis A. Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells. J Hypertension 1993: 11: 1171-1178.
Salerno S M. Zugibe F T. Calcim channel antagonists. What do the second-generation agents have to offer? Postgrad Med 1994: 95: 181-190.
Zwieten P A. Protective effects or calcium antagonists in different organs and tissues. Am Heart J 1993: 125: 566-571
Kramsch D. Atherosclerosis progression/regression: lipoprotein and vessel wall determinants. Atherosclerosis 1995: 1 18 ( suppl ): S29-S36.
Collins P. Fox K. The pathogenesis of atherorna and the rationale for its treatment. Eur Heart J 1992: 13: 560-565.
Mozar H N, Bal D G. Farag S A. The natural history of atherosclerosis: an ecologic perspective. Atherosclerosis 1990: 82: 157-164.
Melnick J L. Adam E. DeBakey M E. Cytomegalovirus and atherosclerosis. Eur Heart J 1993: 14 (suppl K): 30-38.
Visser M R. Vercellotti G M. Herpes simplex and atherosclerosis. practice of infectious diseases. EUr Heart J 1993: 14 (Suppl K): 39-42
Burch G E. Viruses and arteriosclerosis. Am Heart J 1974: 87: 407-412.
llbäck N-G. Mohammed A. Fohlman J. Friman G. Cardiovascular lipid accumulation with coxsackie B vírus infection in mice. Am J Pathol 1990: U6: 159-167.
Fabricant C G. Fabricant J. Litrenta M M. Minick C R. Vírus induced atherosclerosis. J Exp Med 1978: 148: .B5-340.
Gyorkey F. Melnick J L. Guinn G A. Gyorkey P. Debakey M E. Herpes viridae in the endothelial and smooth muscle cells of the proximal aorta of atherosclerotic patients. Exp Mol Pathol 1984: 40: 328-339
Hajjar D. Pomerantz K. Falcone D. Weksler B. Grant A J. Herpes simplex vírus infection in human arterial cells. lmplications in arteriosclerosis. J Clin lnvest 1987: 80: 1317-1321.
Yamashiroga H M. Ghosh L. Yang R. Robertson L. Herpesviridae in the coronary arteries and aorta or young trauma victims. Am J Pathol 1988: 130: 71-79.
Kaner R J. Hajjar D P. Viral genes and atherosclerosis. Em: Luisis A J, Rotter J I. Sparkes R S. (eds.): Molecular genetics of coronary artery disease. Candidate Genes and processes in atherosclerosis. Monogr Hum Genet. Karger. Basel 1992: 14: 62-81.
Span A. Van Boven C. Bruggeman C A. The effect or CMV infection on the adherence of polymorphonuclear leucocytes to endothelial cells. Euro J Clin lnvest 1989: 19: 542-548.
Visser M R. Tracy P B. Vercellotti G M. Goodman J L. White J G. Jacob H S. Enhanced thrombin generation and platelet binding on herpes
simplex virus-infected endothelium. Proc Natl Acad Sci USA 1988: 85: 8227-8230.
Lemström K B. Aho P T. Bruggeman C A. Häyry P J. Cytomegalovirus infection enhances mRNA expression of platelel derived growth factor-BB and transforming growth factor-b 1 in rat aortic allografts. Arterioscl Thromb 1994: 14: 2043-2052.
Visser M R. Jacobs H S. Goodman G L. McCarthy J B. Furtch L T. Vercellotti G M. Granulocyte-mediated injury to herpes simplex virus-infected human endothelium. Lab lnvest1989: 60: 296-304.
Key N S. Vcrcellotti G M. Winkelmann JC. Moldow C F. Goodman J L. Esmon N L. Esmon C T. Jacob H S. lnfection of vascular endothelial cells with herpes simplex vírus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci USA 1990: 87: 7095- 7099.
Van Dam-Mieras M. Bruggeman C. Muller A. Debie W. Zwaal RF. lnduction of endothelial cell procoagulant activity by cytomegalovirus infection. Thromb Res 1987: 47: 69-75
Visser MR. Vercellotti GM. McCarthy JB. Goodman JL. Herbst TJ. Furcht LT. Jacob H S. Herpes simplex vírus inhibits endothelial cell attachment and migration to extracellular matrix proteins. Am J Pathol 1989: J:14: 223-230.
Macarek E J. Friedman H M. Kefalides N A. Herpes simplex virus type I infection or endnthelium reduces collagen and fibronectin synthesis. Lab lnvest 1985: 5.l: 280-286.
Etingin O, Hajjar D. Evidence for cytokine regulation of cholesterol metabolism in herpesvirus-infected arterial cells by the lipoxygenase pathway. J Lipid Res 1990:31 :299-.105.
Sorlie P D. Adam E. Melnick S L. Folsom A. Skelton T. Chambless L E. Barnes R. Melnick. Cytomegalovirus/Herpevirus and carotid atherosclerosis: the ARIC study. J Med Virology 1994: 42: 33-37
Nieto F. Adam E. Sorlie P. Farzadegan H. Melnick J. Comstod, G. Szklo M. Cohort stucJy of cytornegalovirus infection as a risk factor for carotid intimal-medial thickening. a measure of subclinical atherosclerosis. Circulation 1996: 94: 922-927.
Haines, A. Peckham C. lmeson J. Singh M. Cytomegalovirus and atherosclerosis. Lancet 1987: 2: 291-293.
Melnick J L. Viroses e aterosclcrose. Vector 1991: 6: 1-4.
Melnick J L. Hu C. Burek J. Adam E. DeBakey M E. Cytomegalovirus DNA in arterial walls of palients with atherosclerosis. J Med Virol 1994: 42: 170-174.
Adam E. Melnick J L. Probtsfield J L. Petrie B L. Burek J, Bailey K R. McCollum C H. DeBakey M E. High leveis of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987: 2: 291-293.
McDonald K. Rector T S. Braulin E A. Kubo S H. Olivari M T. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989: 64: 359.
Sharples L D. Caine N. Mullins P. Scott J P. Solis E. English TA, Large S R. Schofield P M. Wallwork J. Risk factor analysis for the major hazards following heart transplantation - rejection. infection. and coronary occlusive disease. Transplantation 1991: 52: 244-252.
Banga J D. Visseren F L J. Bouter K P. Hoekstra J B L. Pon M J. Erkelens D W. Atherosclerosis and cytomegalovirus in patients with diabetes mellitus. 62nd EAS Congress Abstracts 1993. pág 28.
Hendrix M G R. Dormans P H J. Kitslaar P. Bosman F. Bruggeman C A. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerolic patients. Am J Pathol 1989: 134: 1151-1157.
Hendrix M G R. Daemen M. Bruggeman C A. Cytomegalovirus nucleic acid distribution within the human vascular tree. Am J Pathol 1991: 138: 563-567.
Hendrix M G R. Salimans M M M. Van Boven C P A. Bruggeman C A. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990: 136: 2.1-28.
Pyrzak R. Shih C H. Detection of specific DNA segments of Marek's disease herpes virus in japanese quail susceptible to atherosclerosis. Atherosclerosis 1987: 68: 77-85.
Melnick J L. Dreesman G R. McCollum C H. Petrie B L. Burek J. DeBakey M E. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983; 2: 644-647.
Kos W L. Loria R M. Snodgrass M J. Cohen D. Thorpe T G. Kaplan A M. lnhibition of host resistance by nutritional hypercholesterolemia. lnfect Immun 1979: 26: 658-667.
Loria R M. Kibrick S. Madge G E. lnfection of hyper cholesterolemic mice with coxsakievirus B. J lnfect Dis 1976: 133: 655-662.
Benditl E P. Bendill J M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973: 70: 1753.
Benditt E P. Origins of human atherosclerotic plaques. The role of altered gene expression. Arch Pathol Lab Me 1988: 112: 997-1001.
Csonka E. Bayer P 1. Buki K. Varady G. lnfluence of the measles virus on lhe proliferation and protein synthesis of aortic endothelial and smooth muscle cells. Acta Microbiol Hung 1990: 37: 193-200.
Gabaldón M. Capdevila C. Adhesion of leukocytes to the aortic endothelium of conventional, specific pathogen free (SPF) and hypercholesterolemic SPF rats. Alherosclerosis 1989: 75: 83-92.
Melnick S L. Shahm- E, Folsom A R. Grayston J T. Sorlie P D. Wang S-P. Szklo M. Past infection by chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 1993: 95: 499-504.
Miragliotta G. Dei Prete R. Mosca A. Helicobacter pylori infection and coronary heart disease. Lancet 1994: 344: 751.
Saikku P, Mattila K. Nieminen M S. Huttunen J K, Leinonen M. Ekman M-R. Mäkelä P H. Valtonen V. Serological evidence of an association of a novel chlamydia. twar. with chronic coronary heart disease and acute myocardial infarction. Lancet 1988: 2: 983-985.
Grayston J. Antibiotic treatment trials for secondary prevention of coronary artery disease events. Circulation 1999: 99: 1538-
Anderson J. Muhlestein J. Carlquist J. Allen A. Trehan S. Nielson C, Hall S. Brady J. Egger M. Horne B. Lim T. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for chlamydia pneumoniac infection. The azithromycin in coronary artery disease: elimination of myocardial infection with chlarnydia (ACADEMIC) Study. Circulation 1999: 99: 1540-1547.
Torgano G. Cosentini R. Mandelli C. Perondi R. Blasi F. Bertinieri G. Tien T, Ceriani G, Tarsia P. Arosio C. Ranzi M. Treatment of helicobacter pylori and chlamydia pneumoniac infections decreases fibrinogen plasma level in patients with ischemic heart disease. Circulation 1999: 99: 1555-1559.
Bartels C. Maass M. Bein G, Malisius R. Brill N. Bechtel J. Sayk F. Feller A, Sievers H-N. Detection of Chlamydia pneumoniac but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts. Circulation 1999: 99: 879-882.
Dechend R. Maass M, Gieffers J. Dietz R. Scheidereit C. Leutz A. Gulba D. Chlamydia pneumoniac infection of vascular smooth muscle and endothelial cells activates NF-kB and induces tissue factor and PAI-I expression. A potential link to accelerated arteriosclerosis. Circulation 1999: 100: 1369- 1373.
Cammarota G. Pasceri V. Papa A. Cianci R. Gasbarrini A. Fedeli P, Cremonini F. Fedeli G. Maseri A. Gasbarrini G. Helicobacter pylori infection and ischaemic heart disease. Ital J Gastroenterol Hepatol 1998; 30 Suppl 3: S304-306.
Epstein S. Zhu J. Lack of association of infectious agents with risk of future myocardial infarction and stroke. Definitive evidence disproving the infection/coronary artery discase hypothesis? Circulation 1999: 100: 1366-1368.
Bimie D. Holme E. McKay 1. Hood S. McColl K. Hillis W. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J 1998: 19: 387-394.
Stehbens W E. The lipid hypothesis of atherogenesis. R G Landes Company, Austin 1993, 185 pp.
Smith E B. Fibrinogen, fibrin, and fibrin degradation products in relation to atherosclerosis. Clin Haematol 1986: 15: 357-370.
Spagnoli L. Mauriello A, Palmieri G. Santeusanio G. Amante A. Taurino M. Relationship between risk factors and morphological patterns of human carotid atherosclerotic plaques. A multivariate discriminant analysis. Atherosclerosis 1994: 108: 39-60.
Hishikawa K, Nakaki T. Marumo T. Hayashi M. Suzuki H. Kato R. Saruta T. Pressure promotes DNA synthesis in rat cultured vascular smooth muscle cells. J Clin lnvest 1994: 93: 1975- 1980.
. Gibson C M. Sandor T. Stone P H. Pasternak R C. Rosner B. Sacks F M. Quantitative angiographic and statistical methods to assess serial changes in coronary lumen and implications for atherosclerosis regression triais. Am J Cardiol 1992: 69: 1286-1290.
Stehbens W E. The lipid hypothesis and the role of hemodynamics in atherogenesis. Prog Cardiovasc Dis 1990: 33: 119-136.
Demer L L. Mechanical factors in artery wall function and atherogenesis. Em: Lusis A J. Rotter J I. Sparkes R S. (eds.): Molecular genetics of coronary artery disease. Candidate Genes and processes in atherosclerosi,. Monogr Hum Genet. Karger. Basel 1992:14:82-97.
Herman I M. Brant A M. Warty V S, Bonaccorso J. Klein E C. Kormos R B. Borovetz H. Hemodynamics and the vascular endothelial cytoskeleton. L Cell Biol 1987: 105: 291-302.
Booth R F G. Martin J F. Honey AC. Hassall D G. Beesley J E. Moncada S. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 1989: 76: 257-268.
Bettencourt M J. Elasticidade e viscoelasticidade no aparelho circulatório. I. Fundamentos físicos. II. Artérias. Rev Port Cardiol 1994: 13: 337-354.
Kensey K R. A theory implicating protective adaptation to chronic mechanical injury as the etiology of arterial occlusive disease. Xth lnternational Symposium on Atherosclerosis· Abstracts. Atherosclerosis 1994: 109 ( 1.2): 33
Chobanian A V. The effects of ACE inhibitors and other antihypertensive drugs on cardiovascular risk factors and atherogenesis. Clin Cardiol 1990: 13: VII 43-48.
Gohlke P. Lamberty V. Kuwer 1. Bartenbach S. Schnell A. Unger T. Vascular remodeling in systemic hypertension. Am J Cardiol 1993: 71: 2E-7E.
Levy B 1. Michel J B. Salzmann J L. Poitevin P. Devissaguet M. Scalbert E. Safar M E. Long-term effect, of angiotensin converting enzyme inibition on the arterial wall or adult spontaneously hypertensive rats. Am J Cardiol 1993: 71: 8E 16E.
Doyle A E. ACE inhibition: benefits beyond blood pressuré control. Am J Med 92 (suppl 4B): IS-2S.
Rossi GP. Rossi A. Sacchetto A. Pavan E. Pessina A C. Hypertensive cerebrovascular disease and the renin-angiotensin system. Stroke 1995: 26: 1700-1706.
Fyhrquist F. Metsärinne K. Tikkanen 1. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. J Human Hypertens 1995: 9 (suppl 5): Sl9-S24.
Pepine C J. Angiotensin converting enzyme inhibition and coronary artery disease. J Hypertens 1994: 12 (suppl 4 ): S65- S71.
Schuh J R. Blehm D J. Frierdich G E. McMahon E G. Blainc E H. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin lnvest 1993: 91: 1453-1458.
Maclsaac A I. Thomas J D. Topol E J. Toward the quiescent coronary plaque. JACC 1993: 22: 1228-1241.
Gertz S D. Roberts W C. Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol 1990: 66:, 1368-1171.
Ando J. Kamiya A. Blood flow and vascular endothelial function. Front Med Biol Eng 1993: 5: 245-264.
Colangelo S. Langille B L. Gotlieb A I. Endothelial microfilament distribution in the immediate vicinity of arterial branch sites. Xth lnternational Symposium on Atherosclerosis· Abstracts. Atherosclerosis 1994: 109 ( 1.2): 186.
Frieelman M H. Some atherosclerosis may be a consequence of the normal adaptive vascular response to shear. Atherosclerosis 1990 (82): 193-196.
Sterpelli A V. Cucina A. D'Angelo L S. Cardillo B. Cavallaro A. Shear stress modulates the proliferation rate. protein synthesis. and mitogenic activity of arterial smooth muscle cells. Surgery 1993: 113: 691-699.
Sprague E A. Steinbach B L. Nerern R M. Schwartz C J. lnfluence of a laminar steady-state fluid-imposeel wall shear stress on the binding. internalization and degradation of low-density lipoprotein, by cultured arterial endothelium. Circulation 1987: 76: 648-656.
Resnick N. Sumpio B. Gimhrone M. Endothelial gene regulationby biomechanical forces. Xth lnternational Syrnposium on Atherosclerosis· Abstracts. Atherosclerosis 1994: 109 ( 1.2): 344.
Vanhoutte P M. Rubany G M. Miller V M. Houston D S. Modulation of vascular smooth muscle contraction by enelothelium. Ann Rcv Physiol 1986: 48: 307-320
, Davies P F. Olesen S P. Clapham D E. Morrel E M. Schoen F J. Endothelial communication. State of the art lecture. Hypertension 1988: 11: 563-572.
Lansman J B. Hallam T J. Rink T J. Single stretch-activated ion channels in vascular endothelial cells as mechanostransducers Nature 1987: 325: 811-813.
Lansman J B. Enelothelial mechanosemors - going with the flow. Nature 1988: 331: 481.
Olesen S P. Clapham D E. Davies P F. Haernodynamic shear stress activatcs a K+ current in vascular endothelial cells. Nature 1988: 331: 168-170.
Williams K J. Tabas I. The response-10-relention hypothesis of early atherogenesis. Arterioscl Thromb Vasc Biol 1995: 15: 551- 561.
Thubrikar M J. Pressure-induced wall stress. atherosclerosis. and heta blockers. Xth lnternational Symposium on Atherosclerosis, Abstracts. Atherosclerosis 1994: 109 ( 1.2): 265.
Fry D L. Certain histological and chemical responses of the vascular interface to acutely induced mechanical stress in the aorta of the dog. Circ Res 1969: 24: 93-108.
Asakura T. Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ Rcs 1990: 66: 1045-1066.
Gibson C M. Diaz L. Kandarpa K. Sacks F M. Pasternak R C. Sandor T. Feldman C. Stone P H. Relation of vessel wall shaer stress to atherosclerosis progression in human coronary arteries. Arterioscler Thromb 1993: 13: 310-315.
McMillan D E. Blood flow and the localization of atherosclerotic plaques. Stroke 1985: 16: 582-587.
Smedbyy Ó. Jahansson J. Mölgaard J. Olsson A G. Walldius G. Erikson U. Predilection of atherosclerosis for the inner curvature in the femoral artery. A digitized angiography study. Arterioscl Thromb Vasc Biol 1995: 15: 912-917.
Fuster V. Badimon L. Badimon J J. Chesebro J H. The pathogenesis of coronary artery disease and the acute coronary syndromes (2nd of two parts). N Engl J Med 1992: 326: 310-318.
Walpola P L. Gotlieb A 1. Cybulsky M 1. Langille B L. Expression of icam-I and vcam-I and monocyte adherence in arteries exposed to altered shear stress. Arterioscl Thromb Vasc Biol 1995: 15: 2-10.
Hasdai D. Lerman A. The atherogenic potential of endothelin. Coronary Artery Ois 1995: 6: 901-904.
Lerman A. Hildebrand Jr F L. Margulies K B. O'Murchu B. Perrella M A. Hcublein D M. Schwab T R. Burnell J C. Endothelin: a new cardiovascular regulatory peptide. Mayo Clin Proc 1990: 65 1441-1455.
Yoshizurni M. Kurihara H. Sugiyarna T. Takaku F. Yanagisawa M. Masaki T. Yazaki Y. Hernoelynarnic shear stress stimulates endothelin reduction by cultured endothelial cells. Biochem Biophys Res Commun. 1989: 161: 859-864.
Caro C. Arterial fluid mechanics and atherogenesis. Clinical Hemorheology 1982:2: 131-136.
Okano M. Yoshida Y. lnfluence of shear stress on endothelial cell shapes and junction complexes at flow dividers of aortic bifurcations in cholesterol fed rabbits. Frnnl Mec.l Biol Eng 1993: 5: 95-120.
Glagov S. Zarins C, Giddens D. Ku D N. Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 1988: 1 12: 1018-1031.
Yoshida Y. Mitsumala M. Yamane T. Wang S. Arisaka T. Kawasumi M. Okano M. lnfluence of flow on endothelial tight junction and extracellular matrix. Xth lnternational Symposium by biomechanical forces. Xth lnternational Syrnposium on Atherosclerosis· Abstracts. Atherosclerosis 1994: 109 ( 1.2): 344.
Glagov S. Weisenberg E. Zarins C K. Stankunaviciu, R. Kolettis G J. Compensatory enlargement of human atherosclerotic
coronary arteries. N Engl J Med. 1987: 316: 1371-1375.
Zarins C K. Zatina M A. Giddens D P. Ku D N. Glagov S. Shear stress regulation of artery lumen diameter in experimental atherogenesis. J Vasc Surg 1987: 5: 413-420.
Rubanyi G M. Romero J C. Vanhoutte P M. Flow-induced release of endothelium-derived relaxing factors. Am J Physiol 1986: 250: H 1145-1149.
Glagov S. Zarins C K. Giddens D P. Hemodynamics. the structure of the artery wall and atherosclerosis. Xth lnternational Symposium on Atherosclerosis' Abstracts. Atherosclerosis 1994: 109 (1.2): 343.
Thubrikar M J. Moorthy R R. Deck J D. Nolan S P. Smooth muscle cell proliferation: is it due to endothelial injury or aortic stretch''. Xth lnternational Symposium on Athcrosclcrosis· Abstracts. Atherosclcrosis 1994: 109 ( 1.2): 100.
Trabulo M. Silva J A. Mesquita A. Paios J L. Seabra-Gomes R. Valor preditivo da coronariografia na localização da lesão arterial responsável por futuro enfarte do miocárdio. Rev Port Cardiol 1996: 15 (1): 11-16.
Stary H. Chandler A. Dinsmore R. Fuster V. Glagov S. lnsull W. Rosenfeld M. Schwarlz C. Wagner W. Wissler R. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscl Thromb Vasc Biol 1995: 15: 1512-1531.
Stary H C. Natural hystory of the human atherosclerotic lesion. Xllh lnternational Symposium on Atherosclerosis· Abstracts. Atherosclerosis 1997: 134 (1.2): 10-11.
Foegh M L. Accelerated cardiac transplant atherosclerosis/chronic rejection in rabhits: inhibiton by angiopeptin. Transplant Proceed 1993: 25: 2095-2097.
Cooke T. Sheahan R. Foley D. Reilly M. D"Arcy G. Jauch W, Gihney M. Gearty G. Crean P. Walsh M. Lipoprotein(a) in restenosis afler perculaneous transluminal coronary angioplasty and coronary artery disease. Circulation 1994: 89: 1593- 1598.
Eber B, Schumacher M. Tatzber F. Kaufman P. Luha O. Esterbauer H. Klein W. Autoantibodies to oxidized low density lipoproteins in restenosis following coronary anginplasty. Cardiology 1994: 84: 310-315.
Fishman R F. Kuntz R E. Carrosa J P Jr. Miller M J. Senerchia C C. Schnitt S J. Diver D J. Safian R D. Bairn D S. Long-term results of directional coronary atherectomy: predictors of restenosis. J Am Coll Cardiol 1992: 20: 1101-1110.
Gürlek A. Dagalp Z. Oral D. Ómürlü K. Erol Ç. Akyol T. Tutar E. Restenosis after transluminal coronary angioplasty: a risk factor analysis. J Cardiovasc Risk 1995: 2: 51-55.
Riiisiinen-Sokolowski A. Tilly-Kiesi M. Ustinov J. Mennander A, Paavonen T, Tikkanen M J. Hiiyry P. Hyperlipidemia accelerates allograft artcriosclerosis (chronic rejection) in the rat. Arterioscl Thromh 1994: 14: 2032-2042.
Capron L. Cause de l'athérosclérose: l'hypoltese virale. Arch Mal Coeur 1987: 80' année (nº spécial Sept.): 51-55.
Thompson W D. Smith E B. Atherosclerosis and the coagulalion system. J Pathol 1989: 159: 97-106.
Peres E. Moreira P. Alimentação de adolescentes e prevenção de doenças cardiovasculares. Endocrinol Metab Nutr 1993: 2: 267-
Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolemia. BMJ 1991: 303: 893-899.
Lorgeril M. Renaud S. Mamelle N. Salen P. Martin-J-L. Monjaud 1, Guidollet J. Touboul P. Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994: 343: 1454-1459.
Reis L. Correia F. Gorduras alimentares e nutrição. Endocrinol Metab Nutr 1993: 2: 399-407.
Levine G N. Keaney J F Jr. Vila J A. Cholesterol reduction in cardiovascular disease. Clinical bencfits and possible mechanism... N Engl J Med 1995: 332: 512-521.
Silva P S. Aterogénese experimental no rato. Contribuição para o estudo de um modelo dietético. Dissertação de Doutoramento. edição do autor. Coimbra 1972.
Cardoso S. Estratégias das medidas preventivas. Rev Port Cardiol 1995: 14: 543-550.
Ficheiros Adicionais
Publicado
Como Citar
Edição
Secção
Licença
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Direitos de Autor (c) 2023 Medicina Interna
Acesso livre
